Issue 6/2003
Content (7 Articles)
Original Article
Lack of dendritic cell mobilization into the peripheral blood of cancer patients following standard- or high-dose chemotherapy plus granulocyte-colony stimulating factor
Silvia Ferrari, Bianca Rovati, Camillo Porta, Paolo Emilio Alessandrino, Alessandro Bertolini, Elena Collovà, Alberto Riccardi, Marco Danova
Symposium Series
International conference: Progress in vaccination against cancer (PIVAC) 2002, Nottingham, UK
Robert C. Rees, R. Adrian Robins, Graham Pawelec, Ludmila Muller, Geng Li, Ian Spendlove
Original Article
Interferon-α and interleukin-12 gene therapy of cancer: interferon-α induces tumor-specific immune responses while interleukin-12 stimulates non-specific killing
Jun-ichi Eguchi, Kazumasa Hiroishi, Shigeaki Ishii, Keiji Mitamura
Original Article
Durable complete clinical responses in a phase I/II trial using an autologous melanoma cell/dendritic cell vaccine
Michael G. E. O'Rourke, Maree Johnson, Catherine Lanagan, Janet See, Jie Yang, John R. Bell, Greg J. Slater, Beverley M. Kerr, Beth Crowe, David M. Purdie, Suzanne L. Elliott, Kay A. O. Ellem, Christopher W. Schmidt
Original Article
A new small cell lung cancer (SCLC)-specific marker discovered through antigenic subtraction of neuroblastoma cells
Pamela Krueger, Christina Nitz, Randi Foster, Colleen MacDonald, Oren Gelber, Guita Lalehzadeh, Robert Goodson, Jill Winter, Cohava Gelber
Original Article
Optimization of dendritic cell maturation and gene transfer by recombinant adenovirus
George Miller, Svenja Lahrs, Alaap B. Shah, Ronald P. DeMatteo
Original Article
High levels of Fas ligand and MHC class II in the absence of CD80 or CD86 expression and a decreased CD4+ T cell Infiltration, enables murine skin tumours to progress
Scott N. Byrne, Gary M. Halliday